Aerosol emission and exposure in non-invasive ventilation

Abstract From the beginning of the COVID-19 pandemic, there has been concern among clinicians whether the use of high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) contributes to aerosol generation and consequently spreading of pathogens. Most guidelines still classify the...

Full description

Saved in:
Bibliographic Details
Main Authors: Petra Nikuri, Anthony Maalouf, Ahmed Geneid, Eero Pesonen, Enni Sanmark, Ville A. Vartiainen
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-98751-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172792180310016
author Petra Nikuri
Anthony Maalouf
Ahmed Geneid
Eero Pesonen
Enni Sanmark
Ville A. Vartiainen
author_facet Petra Nikuri
Anthony Maalouf
Ahmed Geneid
Eero Pesonen
Enni Sanmark
Ville A. Vartiainen
author_sort Petra Nikuri
collection DOAJ
description Abstract From the beginning of the COVID-19 pandemic, there has been concern among clinicians whether the use of high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) contributes to aerosol generation and consequently spreading of pathogens. Most guidelines still classify these treatments as high-risk aerosol-generating procedures. The aim of this study was to evaluate differences in aerosol emissions and exposure with CPAP and HFNC compared to no breathing aid (NBA). Aerosol emissions of 16 healthy volunteers using CPAP, HFNC and NBA were measured with a portable aerosol spectrometer. During each measurement, the volunteers were instructed consecutively to breathe normally, breathe deeply, cough and read aloud a predefined text. The Wilcoxon signed-rank test was used in statistical analysis. Non-invasive ventilation (CPAP, HFNC) does not produce significantly more aerosol than the same respiratory activities without a breathing aid (median CPAP-NBA − 4.54 1/L, p = 0.816, and HFNC-NBA 2.27 1/L, p = 0.244), deep breathing (median CPAP-NBA − 2.27 1/L, p = 0.378 and HFNC-NBA 4.55 1/L, p = 0.623), speaking (median CPAP-NBA 0 1/L, p = 0.0523 and HFNC-NBA 9.09 1/L, p = 0.0140), or coughing (median CPAP-NBA − 17.31 1/L, p = 0.587 and HFNC-NBA 1.92 1/L, p = 0.365). The results indicate that both CPAP and HFNC have no clinically meaningful impact on aerosol emission. Therefore, the use of CPAP or HFNC does not expose healthcare personnel to greater concentrations of aerosols when compared to normal breathing in healthy participants.
format Article
id doaj-art-bc5195fafc6746dbb4734bacce66a32d
institution OA Journals
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-bc5195fafc6746dbb4734bacce66a32d2025-08-20T02:19:58ZengNature PortfolioScientific Reports2045-23222025-04-011511610.1038/s41598-025-98751-0Aerosol emission and exposure in non-invasive ventilationPetra Nikuri0Anthony Maalouf1Ahmed Geneid2Eero Pesonen3Enni Sanmark4Ville A. Vartiainen5Heart and Lung Center, Faculty of Medicine, Helsinki University Hospital, University of HelsinkiDepartment of Otorhinolaryngology ja Phoniatrics - Head and Neck Surgery, University of Helsinki and Helsinki University HospitalDepartment of Otorhinolaryngology ja Phoniatrics - Head and Neck Surgery, University of Helsinki and Helsinki University HospitalDepartment of Anesthesiology and Intensive Care Medicine, University of Helsinki and Helsinki University HospitalHeart and Lung Center, Faculty of Medicine, Helsinki University Hospital, University of HelsinkiHeart and Lung Center, Faculty of Medicine, Helsinki University Hospital, University of HelsinkiAbstract From the beginning of the COVID-19 pandemic, there has been concern among clinicians whether the use of high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) contributes to aerosol generation and consequently spreading of pathogens. Most guidelines still classify these treatments as high-risk aerosol-generating procedures. The aim of this study was to evaluate differences in aerosol emissions and exposure with CPAP and HFNC compared to no breathing aid (NBA). Aerosol emissions of 16 healthy volunteers using CPAP, HFNC and NBA were measured with a portable aerosol spectrometer. During each measurement, the volunteers were instructed consecutively to breathe normally, breathe deeply, cough and read aloud a predefined text. The Wilcoxon signed-rank test was used in statistical analysis. Non-invasive ventilation (CPAP, HFNC) does not produce significantly more aerosol than the same respiratory activities without a breathing aid (median CPAP-NBA − 4.54 1/L, p = 0.816, and HFNC-NBA 2.27 1/L, p = 0.244), deep breathing (median CPAP-NBA − 2.27 1/L, p = 0.378 and HFNC-NBA 4.55 1/L, p = 0.623), speaking (median CPAP-NBA 0 1/L, p = 0.0523 and HFNC-NBA 9.09 1/L, p = 0.0140), or coughing (median CPAP-NBA − 17.31 1/L, p = 0.587 and HFNC-NBA 1.92 1/L, p = 0.365). The results indicate that both CPAP and HFNC have no clinically meaningful impact on aerosol emission. Therefore, the use of CPAP or HFNC does not expose healthcare personnel to greater concentrations of aerosols when compared to normal breathing in healthy participants.https://doi.org/10.1038/s41598-025-98751-0Aerosol emissionHigh-Flow nasal cannula (HFNC)Continuous positive airway pressure (CPAP)Respiratory aerosols
spellingShingle Petra Nikuri
Anthony Maalouf
Ahmed Geneid
Eero Pesonen
Enni Sanmark
Ville A. Vartiainen
Aerosol emission and exposure in non-invasive ventilation
Scientific Reports
Aerosol emission
High-Flow nasal cannula (HFNC)
Continuous positive airway pressure (CPAP)
Respiratory aerosols
title Aerosol emission and exposure in non-invasive ventilation
title_full Aerosol emission and exposure in non-invasive ventilation
title_fullStr Aerosol emission and exposure in non-invasive ventilation
title_full_unstemmed Aerosol emission and exposure in non-invasive ventilation
title_short Aerosol emission and exposure in non-invasive ventilation
title_sort aerosol emission and exposure in non invasive ventilation
topic Aerosol emission
High-Flow nasal cannula (HFNC)
Continuous positive airway pressure (CPAP)
Respiratory aerosols
url https://doi.org/10.1038/s41598-025-98751-0
work_keys_str_mv AT petranikuri aerosolemissionandexposureinnoninvasiveventilation
AT anthonymaalouf aerosolemissionandexposureinnoninvasiveventilation
AT ahmedgeneid aerosolemissionandexposureinnoninvasiveventilation
AT eeropesonen aerosolemissionandexposureinnoninvasiveventilation
AT ennisanmark aerosolemissionandexposureinnoninvasiveventilation
AT villeavartiainen aerosolemissionandexposureinnoninvasiveventilation